Navigation Links
Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
Date:12/19/2007

VALSTAR-specific Issues Have Been Resolved; Remaining Issues Pertain to

cGMP Compliance of Third-party Manufacturing Facility

Company Expects to Resolve cGMP Issues in the Next Several Months

LEXINGTON, Mass., Dec. 19 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that it has received a non-approvable letter from the U.S. Food and Drug Administration (FDA) for VALSTAR(TM) related to its chemistry, manufacturing and controls (CMC) NDA supplement submitted to the FDA in May 2007. The letter was received following the Company's response to an August 2007 approvable letter.

The VALSTAR-specific issues that caused the 2002 withdrawal of the product from the market have been satisfactorily resolved. However, during a recent FDA pre-approval inspection of the Company's third-party manufacturing facility for VALSTAR, deficiencies were identified that require resolution prior to approval. The Company believes that successfully addressing the deficiencies at the manufacturing plant is the only remaining item for product approval. Upon resolution, which the Company expects to occur within several months, the Company will respond to the FDA and request re-inspection of the facility.

"We and our third-party manufacturer firmly believe we will be able to resolve the open cGMP issues within the next several months," stated Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. "We have been in direct communication with the FDA and they have committed to working closely with us and our manufacturer to resolve the open cGMP issues in an expeditious manner. They appreciate the need and desire to return VALSTAR, currently on the FDA Drug Shortages List, to the ma
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Allergan as New Partner for SANCTURA Brand
3. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
6. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
7. IsoTis Receives FDA Clearance for Accell Family of Products
8. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
11. XTL Receives Staff Letter From NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...-- Azur Pharma Limited ("Azur") today,announced t...h BioSante,Pharmaceuticals, Inc ("BioSante")(Nasd...M). Elestrin is a fast drying gel formulation of e...moderate to severe vasomotor symptoms,associated ...Food and Drug,Administration ("FDA") in December ...
(Date:12/4/2008)...stCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH )... has stepped down from his position as a director ...ewis advised the Company that his decision to leav...itments to new leadership positions. , , (L...8/NY46990LOGO ) , , Dr. Harold Koplewicz, C...
(Date:12/4/2008)...rstCall/ -- ExonHit Therapeutics S.A.,(Alternext:...is pleased to,announce today that it has been hon...al Property) during the last edition of its "Troph... "Since its inception, ExonHit consistently made e...s intellectual property and in particular from its...
(Date:12/3/2008)... GlaxoSmithKline,(LSE/NY...ondition relating to a,pending lawsuit in the pre...,the outstanding shares of common stock of Genelab... per share in cash without interest and less any,...tion to the completion of the tender offer that th...
Breaking Biology Technology:Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3
..., , , For fast purification of up to 10 ... , Features and benefits , ,..., Cleared lysates from up to 2.5 liters of..., Reduced plasmid purification time , ...all to large culture volumes , , ,...
..., , , For ultrafast purification of up t..., Features and benefits , , ... harvested culture to , ultrapure DNA ...itation without centrifugation , , ...tion , Up to 200 g (Midi) or 750 g (Max...
..., , , Jochen Meier, Ivonne Strmel, Ra...antyn , Developmental Physiology, Johannes...ical School (Charit), Berlin, Germany , ,...al cell cultures is of critical , importanc...is of neuronal , physiology. Here, we descr...
..., , , Marion Schmidt, Holger Engel, M...by Schulte, Silke Zobel, and Dirk Lffert , ...icrosatellites highly polymorphic DNA markers com...n tandem arrays and distributed throughout the gen...fication of individuals. The , microsatelli...
Other Biology Technology:QIAfilter Plasmid Kits 2HiSpeed Plasmid Kits 2Effectene Transfection Reagent provides efficient gene delivery , to primary neuronal cell cultures 2Effectene Transfection Reagent provides efficient gene delivery , to primary neuronal cell cultures 3Effectene Transfection Reagent provides efficient gene delivery , to primary neuronal cell cultures 4Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 2Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 3Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 4Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 5
(Date:12/3/2008)...mpaign has demonstrated how a technique using lase...the atmosphere. The campaign supports one of the m...COPE mission. , A-SCOPE (Advanced Space Carbon a...the six candidate Earth Explorer missions that has...ept, along with the other five, will be presented ...
(Date:12/3/2008)...December 3, 2008 Today, the International Society...ng professional organization of stem cell research...evelopment of safe and effective stem cell therapi...zes the Guidelines for the Clinical Translation of... December issue of Cell Stem Cell , the official ...
(Date:12/3/2008)...ays can be regarded as safe for pregnancy - other ... , Women can usually keep using the same asthma...udesonide sprays are the best studied and can be r...dicines are necessary however. According to the Ge...h Care (IQWiG), more data from trials could reassu...
(Date:12/2/2008)...fect body may come with some substantial benefits ...December issue of Current Anthropology . , The...e competitive and better able to deal with stress ... waist, according to Elizabeth Cashdan, an anthrop... and situations where women are under pressure to ...
Breaking Biology News(10 mins):ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Pregnant women with asthma can be more confident about some medicines 2Why the 'perfect' body isn't always perfect 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 1Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 3Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2376 1Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2376 2Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2376 3Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2376 4Where and why humans made skates out of animal bones 1719 1Sleep chemical central to effectiveness of deep brain stimulation 8755 1Sleep chemical central to effectiveness of deep brain stimulation 8755 2Sleep chemical central to effectiveness of deep brain stimulation 8755 3
...thology (ASCP) announced that the Society will rec...o continue to provide laboratory training and qual...rely affected by AIDS. The training programs are ... will continue in 2006 through the President,s Eme... from the United States Department of Health and H...
...idually tailored therapiesContinuing its strong su... medications, the National Institutes of Health an...e years to renew its Pharmacogenetics Research Net...rk of scientists will eventually help doctors tail...ake-ups. , Spearheaded by NIH,s National Institut...
...ipation of the University of Navarra has shown how...n, Brucella abortus, escape destruction within the...(macrophages). This research has been published in... is a model of an intracellular parasite, a catego... those of tuberculosis or legionelosis. Brucella p...
...at the University of California, San Diego, in con...orzio Venezia Nuova and Thetis SPA, has launched a...g fundamental information about the effects of sed...t of the historic city of Venice, Italy. , The new...pps, is part of Italy,s broad commitment to safegu...
Other Biology News:Laboratory professionals in Africa receive training under AIDS Relief Plan 2NIH renews network focused on how genes influence drug responses 2NIH renews network focused on how genes influence drug responses 3NIH renews network focused on how genes influence drug responses 4New Scripps Oceanography project to study sediments and ecosystem restoration in Venice lagoon 2New Scripps Oceanography project to study sediments and ecosystem restoration in Venice lagoon 3
Mouse anti-Yersinia pestis F1 antigen, Monoclonal Antibody, Unconjugated Applications: ELISA: Use at an assay dependent dilution. IF: Use at an assay dependent dilution. WB: Use at an assay depe
...edium is specifically formulated for mounting tiss...e been stained with immunohistochemical methods fo... with chromogens, such as AEC, that are alcohol-so...ount dries completely when slides are cover-slippe...
... Vision Mount is formulated for covering tissue s...y stained with chromogens producing alcohol solubl... Application: Vision Mount can be us...quire an aqueous mounting medium, or those that do...
...t polyclonal to JNK1 (phospho T183 + Y185) Immuno...in containing phosphorylated T183/Y185. Reactivit...d Rat. Not yet tested in other species. Backgroun...roups, including the ERK, JNK, and p38 kinases. Th...
Biology Products: